TRANSPOSON-VERMITTELTE MULTIPLEXSEQUENZIERUNG
European patent · EP1327000 · Deleted
Register entry
- Publication number
- EP1327000
- Application number
- EP01952433
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Jul 5, 2001
- Published
- Jul 16, 2003
- Granted
- May 9, 2007
- Deleted
- Jul 31, 2015
- Reason
- Annual fee unpaid
- IPC classes
- C12Q 1/68 (2006.01)
- Priority
- US 216381 P 07.07.2000
- PCT application
- PCT/US2001/021269 05.07.2001
- PCT publication
- WO2002/004674 17.01.2002
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Feb 24, 2016
Deleted, fee unpaid
Published in Swissreg on 24.02.2016
- Apr 4, 2013
Address changed
- Owner
- Aventis Pharmaceuticals Inc., 300 Somerset Corporate Boulevard, Bridgewater, New Jersey 08807, USA → Aventis Pharmaceuticals Inc., 55 Corporate Drive, Bridgewater New Jersey 08807, USA
Published in Swissreg on 04.04.2013
- May 31, 2007
Granted
Published in +pat+ No 10 in 2007
Parties
Inventor
AUGUST, Paul, R.
Danville, NH 03819, US
KEAGLE, Pamela, J.
Leominster, MA 02138, US
LONG, Henry
Cambridge, MA 02138, US
WIENCIS, Anna
Natick, MA 01760, US
CALL, Katherine
Malden, MA 02148, US
DRAPER, Michael
Plaitsow, MA 03865, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.